Article
Targeting androgen receptor in bone marrow mesenchymal stem cells leads to better transplantation therapy efficacy in liver cirrhosis.
Hepatology (Baltimore, Md.) - 1 Apr 2013
Huang Chiung-Kuei, Lee Soo Ok, Lai Kuo-Pao, Ma Wen-Lung, Lin Tzu-Hua, Tsai Meng-Yin, Luo Jie, Chang Chawnshang
Abstract excerpt
UNLABELLED: Transplantation of bone marrow mesenchymal stem cells (BM-MSCs) has been considered as an alternative therapy, replacing liver transplantation in clinical trials, to treat liver cirrhosis, an irreversible disease that may eventually lead to liver cancer development. However, low survi...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
